Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA1 | P23415 | 5/20 | 0.72 |
| ▸ | GLRB | P48167 | 5/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.60 |
| ▸ | SCN1A | P35498 | 1/20 | 0.60 |
| ▸ | TAS2R46 | P59540 | 1/20 | 0.60 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.60 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.60 |
| ▸ | TAS2R10 | Q9NYW0 | 1/20 | 0.60 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29898320 | 1.00 | GLRA1 (0.72) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Iodide SCHEMBL15475785 | 0.87 | GLRA1 (0.73) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| SCHEMBL15348565 | 0.84 | TAS2R10 (0.63) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL29352583 | 0.75 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL93798 | 0.75 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL14047653 | 0.75 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL14117483 | 0.75 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL29362678 | 0.75 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL21985190 | 0.75 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A | |
| Strychnine SCHEMBL14029424 | 0.75 | GLRA1 (1.00) | GLRA1GLRBCYP3A4MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4369933-A1 | NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE AS HERBICIDES | Fortephest Ltd. (IL) | 2024-05-22 | — | — | EP | disclosed |
| US-11977677-B2 | Gesture based user interfaces, apparatuses and systems using eye tracking, head tracking, hand tracking, facial expressions and other user actions | PARSHIONIKAR UDAY (US) | 2024-05-07 | — | — | US | disclosed |
| US-20240081329-A1 | NON-PROTEIN PHENYLALANINE ANALOGUES FOR INHIBITING CYANOBACTERIA AND PLANT GROWTH | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-03-14 | — | — | US | disclosed |
| US-11880918-B2 | Method for dynamic creation of collages from mobile video | Kodak Alaris, Inc. (US) | 2024-01-23 | — | — | US | disclosed |
| EP-4283492-A1 | A METHOD FOR DYNAMIC CREATION OF COLLAGES FROM MOBILE VIDEO | Kodak Alaris Inc. (US) | 2023-11-29 | — | — | EP | disclosed |
| WO-2023131951-A1 | NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE AS HERBICIDES | FORTEPHEST LTD. (IL) | 2023-07-13 | — | — | WO | disclosed |
| EP-3490433-B1 | WEARABLE DEVICE HAVING A DISPLAY, LENS, ILLUMINATOR, AND IMAGE SENSOR | TOBII AB (SE) | 2023-03-08 | — | — | EP | disclosed |
| WO-2023286057-A1 | NOVEL DERIVATIVES OF NON-CODED AMINO ACIDS AND THEIR USE AS HERBICIDES | FORTEPHEST LTD (IL) | 2023-01-19 | — | — | WO | disclosed |
| US-20230004232-A1 | MULTIPURPOSE CONTROLLERS AND METHODS | PERCEPTIVE DEVICES LLC | 2023-01-05 | — | — | US | disclosed |
| EP-3449337-B1 | EYE-TRACKING ENABLED WEARABLE DEVICES | TOBII AB (SE) | 2023-01-04 | — | — | EP | disclosed |
| EP-1832122-A2 | METHOD, SYSTEM, AND PROGRAM PRODUCT FOR MEASURING AUDIO VIDEO SYNCHRONIZATION | Pixel Instruments, Corp (US) | 2007-09-12 | — | — | EP | disclosed |
| US-20070198444-A1 | Interaction device | UNIVERSITY OF CALIFORNIA SAN DIEGO REGENTS OF UNIVERSITY OF CALIFORNIA | 2007-08-23 | — | — | US | disclosed |
| US-20070153125-A1 | Method, system, and program product for measuring audio video synchronization | PIXEL INSTRUMENTS, CORP. (US) | 2007-07-05 | — | — | US | disclosed |
| US-20070153089-A1 | Method, system, and program product for measuring audio video synchronization using lip and teeth characteristics | PIXEL INSTRUMENTS, CORP. (US) | 2007-07-05 | — | — | US | disclosed |
| WO-2007035183-A2 | METHOD, SYSTEM, AND PROGRAM PRODUCT FOR MEASURING AUDIO VIDEO SYNCHRONIZATION INDEPENDENT OF SPEAKER CHARACTERISTICS | PIXEL INSTRUMENTS, CORP. (US) | 2007-03-29 | — | — | WO | disclosed |
| WO-2006113409-A2 | METHOD, SYSTEM, AND PROGRAM PRODUCT FOR MEASURING AUDIO VIDEO SYNCHRONIZATION USING LIP AND TEETH CHARATERISTICS | PIXEL INSTRUMENTS, CORP. (US) | 2006-10-26 | — | — | WO | disclosed |
| US-20060215880-A1 | Method for tracking objects in a scene | AXIS AB (SE) | 2006-09-28 | — | — | US | disclosed |
| US-20060020368-A1 | Robot apparatus and method of controlling the motion thereof | SONY CORPORATION (JP) | 2006-01-26 | — | — | US | disclosed |
| WO-2005115014-A2 | METHOD, SYSTEM, AND PROGRAM PRODUCT FOR MEASURING AUDIO VIDEO SYNCHRONIZATION | PIXEL INSTRUMENTS, CORP. (US) | 2005-12-01 | — | — | WO | disclosed |
| US-20040227856-A1 | Method and apparatus for determining relative timing of image and associated information | PIXEL INSTRUMENTS | 2004-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240081329-A1 | NON-PROTEIN PHENYLALANINE ANALOGUES FOR INHIBITING CYANOBACTERIA AND PLANT GROWTH | GLUL, PAH, PLPBP | GLRA1 314/4885GLRB 101/4885CYP3A4 2331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.